Plus Therapeutics Inc (PSTV)

Institutional ownership reported to the SEC as of Q2 2026, across 28 quarters.

Reporting holders

$2.6M

Reported value

0.0%

Held as options

-2

Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

Filer	Value	Shares	Their book	Held	Change
VANGUARD CAPITAL MANAGEMENT LLC	$1.3M	304,745	0.00%	new	NEW
BlackRock, Inc.	$419.4K	95,983	0.00%	new	NEW
GEODE CAPITAL MANAGEMENT, LLC	$332.9K	76,155	0.00%	new	NEW
VANGUARD FIDUCIARY TRUST CO	$161.1K	36,868	0.00%	new	NEW
Ashton Thomas Private Wealth, LLC	$149.9K	34,306	0.00%	new	NEW
CITADEL ADVISORS LLC	$111.9K	25,597	0.00%	new	NEW
NORTHERN TRUST CORP	$67.8K	15,516	0.00%	new	NEW
WELLS FARGO & COMPANY/MN	$26.9K	6,156	0.00%	new	NEW
Vanguard Global Advisers, LLC	$10.0K	2,282	0.00%	new	NEW
OSAIC HOLDINGS, INC.	$8.7K	2,000	0.00%	new	NEW
Tower Research Capital LLC (TRC)	$8.5K	1,955	0.00%	new	NEW
UBS Group AG	$2.1K	470	0.00%	new	NEW
Allied Private Wealth LLC	$1.9K	496	0.00%	new	FIRST
SBI Securities Co., Ltd.	$1.1K	251	0.00%	2q	-90.5%-$10.5K
MORGAN STANLEY	$808	185	0.00%	new	NEW
BARCLAYS PLC	$420	96	0.00%	new	NEW
MERCER GLOBAL ADVISORS INC /ADV	$280	64	0.00%	new	NEW
CITIGROUP INC	$74	17	0.00%	new	NEW
Virtu Financial LLC	$67	15,343	0.00%	new	NEW
Caitong International Asset Management Co., Ltd	$52	12	0.00%	new	NEW
HRT FINANCIAL LP	$50	11,612	0.00%	new	NEW
Global Retirement Partners, LLC	$17	4	0.00%	new	NEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

Quarter	Holders	Value	Shares	New	Added	Trimmed	Options
Q2 2026	20	$2.6M	603,158	18	0	1	0.0%
Q1 2026	22	$1.5M	9,125,725	5	5	2	0.0%
Q4 2025	25	$5.7M	11,043,502	9	8	1	0.0%
Q3 2025	22	$3.6M	5,204,331	11	7	3	0.0%
Q2 2025	18	$131.6K	378,210	8	3	4	0.0%
Q1 2025	15	$234.7K	247,066	5	3	2	0.0%
Q4 2024	11	$779.9K	678,174	1	2	0	0.0%
Q3 2024	11	$980.7K	671,685	1	3	2	0.0%
Q2 2024	12	$1.0M	681,694	4	3	0	0.0%
Q1 2024	9	$151.0K	83,672	0	3	1	0.0%
Q4 2023	11	$189.6K	107,024	2	4	1	0.0%
Q3 2023	11	$102.9K	76,785	4	2	2	0.0%
Q2 2023	7	$205.5K	101,711	7	0	0	0.0%
Q1 2023	18	$488.9K	1,685,775	3	3	4	0.0%
Q4 2022	20	$716.1K	2,257,561	7	1	3	0.0%
Q3 2022	20	$1.6M	3,547,093	3	2	6	0.0%
Q2 2022	19	$1.9M	3,578,458	5	4	4	0.0%
Q1 2022	15	$3.3M	3,257,793	3	3	3	0.0%
Q4 2021	16	$2.1M	1,960,211	5	5	0	0.0%
Q3 2021	12	$2.5M	1,299,170	1	3	5	0.0%
Q2 2021	15	$4.1M	1,607,590	9	4	1	0.0%
Q1 2021	8	$717.0K	299,135	2	5	0	0.0%
Q4 2020	11	$768.0K	380,803	2	4	3	0.0%
Q3 2020	12	$875.0K	341,951	6	0	1	0.0%
Q2 2020	6	$552.0K	260,246	1	1	0	0.0%
Q1 2020	7	$457.0K	243,360	2	1	1	0.0%
Q4 2019	11	$1.3M	532,958	6	3	0	0.0%
Q3 2019	12	$1.4M	399,824	12	0	0	0.0%